Verition Fund Management
CO

Verition Fund Management’s Global Cord Blood Corporation CO Stock Holding History

Verition Fund Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-84,017
Closed -$352K – 3266
2021
Q4 		$352K Hold
84,017
– – ﹤0.01% 1898
2021
Q3 		$392K Buy
+84,017
New +$412K ﹤0.01% 1328
2015
Q3 		– Sell
-12,779
Closed -$79K – 829
2015
Q2 		$79K Buy
+12,779
New +$78.4K 0.01% 565

Other funds holding CO

OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Verition Fund Management's CO Position: Q1 2022 in Review

Verition Fund Management sold out of Global Cord Blood Corporation (CO) in Q1 2022, closing a stake of 84,017 shares — an estimated $352K sold.

Verition Fund Management first reported a position in CO in Q2 2015 and held it in 3 quarters. The position peaked at $392K in Q3 2021. 29 funds tracked by Wall St. Rank hold CO as of Q1 2022.

  • Verition Fund Management reported no remaining Global Cord Blood Corporation position as of Q1 2022 after selling out during the quarter.
  • Verition Fund Management sold 84,017 Global Cord Blood Corporation shares in Q1 2022, an estimated $352K.
  • Verition Fund Management first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 3 quarters.
  • Verition Fund Management's Global Cord Blood Corporation position peaked at $392K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2022.

Based on Verition Fund Management's 13F filing for Q1 2022, filed 13 May 2022.